Orion Infusion Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 5 Fair Values set on narratives written by author
ORIONINFU Community Narratives
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Orion Infusion Limited Key Details
About ORIONINFU
- Founded
- 1983
- Employees
- 563
- CEO
- Website
View website
Orion Infusion Limited manufactures and sells large volume parenteral and other lifesaving injectable products in Bangladesh. The company offers I.V. rehydration, electrolyte, and acidosis solutions; ranitidine I.V. infusion; anti-microbial products; metronidazole I.V; pure steam generated fluids; and amino acids solution. It also provides sterile and nonpyrogenic solution, such as Dextrolac, Dianak, Hartman, Manisol, Plasmasol, and Proliv; hypertonic solution, including Dextrosal, Electrodex-10, Fructose – 10, Orlev, Ortac; Dextropac, an isotonic solution; Intralipid 10, a fat emulsion for intravenous use; Maprocin, a fluorinated quinolone antimicrobial agent; and Salpac, a sterile and nonpyrogenic solution. The company was formerly known as Mala Chemical & Pharmaceuticals Industries Ltd. and changed its name to Orion Infusion Limited in 1994. Orion Infusion Limited was incorporated in 1983 and is based in Dhaka, Bangladesh.